Stay updated on Incyte Press Releases

Sign up to get notified when there's something new on the Incyte Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Incyte Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added two December 22, 2025 press releases about Minjuvi approval in Japan and Zynyz approval for first-line advanced anal cancer, plus a December 18, 2025 entry about an upcoming investor conference. Deleted the December 1, 2025 appointment of Richard Hoffman as EVP and GC, and the November 17, 2025 CHMP opinion and the November 19, 2025 investor-conferences item from the list.
    Difference
    6%
    Check dated 2025-12-24T23:24:52.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New press releases dated December 17, 2025 and December 12, 2025 were added to the press releases listing. Older items from November 2025 were removed.
    Difference
    6%
    Check dated 2025-12-17T19:47:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added December 8, 2025, December 7, 2025, and December 3, 2025 press releases, and removed older releases from the listing.
    Difference
    5%
    Check dated 2025-12-10T18:29:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Two new press releases dated December 2, 2025 and December 1, 2025 were added (Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding; Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel), and two October 2025 releases were removed.
    Difference
    6%
    Check dated 2025-12-03T15:22:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a new press release entry 'Incyte to Present at Upcoming Investor Conferences' (November 19, 2025) and removed the older 'Incyte to Report Third Quarter Financial Results' (October 8, 2025) from the Press Releases page.
    Difference
    1%
    Check dated 2025-11-26T13:51:16.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A new press release entry titled Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL) dated November 17, 2025 was added to the Press Releases page. The list now displays 1-10 of 53 items, reflecting the addition and the removal of an older entry.
    Difference
    1%
    Check dated 2025-11-19T08:32:15.000Z thumbnail image

Stay in the know with updates to Incyte Press Releases

Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.